Disseminated Intravascular Dic Auto Saved]

download Disseminated Intravascular Dic Auto Saved]

of 35

Transcript of Disseminated Intravascular Dic Auto Saved]

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    1/35

    Presented by

    Chandika Dahal

    Bsc.mlt 6th sem

    Nobel college

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    2/35

    CONTENTS

    y Introduction

    y Causes

    y Pathophysiologyy Coagulation

    y Signs and symptoms(clinical features)

    y Conditions

    y

    Diagnosisy Treatment

    y Summary

    y References

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    3/35

    INTRODUCTIONy Also known as disseminated intravascular coagulopathy or

    consumptive coagulopathy.

    y It is pathological activation of coagulation(blood clotting)mechanism that happens in response to a variety ofdiseases.

    y It is a hemorrhagic disorder in which the diffuse

    intravascular coagulation causes haemostatic defect.y DIC leads to the formation of small blood clots inside the

    blood vessels throughout the body.

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    4/35

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    5/35

    An acquired syndrome characterized by the intravascularactivation of coagulation with loss of localization arising

    from different causes. It can originate from and causedamage to the microvasculature, which if sufficientlysevere, can produce organ dysfunction

    Taylor, FB, et al. Thromb Haemost 2001;86:1327

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    6/35

    DICy An acquired syndrome

    characterized bysystemic intravascular

    coagulationy Coagulation is always the

    initial event.y Most morbidity and

    mortality depends on

    extent of intravascularthrombosisy Multiple causes

    6

    ThrombosisThrombosis

    FibrinFibrin

    Red Blood CellRed Blood Cell

    PlateletPlatelet

    WWW. Coumadin.com

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    7/35

    DICy An acquired syndrome

    characterized bysystemic

    intravascularcoagulation

    y Coagulation is always theinitial event

    SYSTEMIC ACTIVATION

    OF COAGULATION

    Intravascular deposition

    offibrin

    Depletionofplateletsandcoagulation

    factors

    Thrombosisofsmalland

    midsizevesselsBleeding

    OrganfailureDEATHDEATH

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    8/35

    CAUSES

    y It may be acute ,subacute or chronic.

    y Cancers of lungs,pancreas,prostate,and stomach as well as

    acute myeloid leukemia(particularlyAPML).y Obstetric:abruptio placentae,pre-eclampsia,amniotic fluid

    embolism.

    y Massive tissue injury:Trauma,burns,extensive surgery.

    y Infections: Gram negative sepsis,Neisseriameningitidis,streptococcuspneumoniae,malaria,histoplasmosis,asperillosis,Rockeymountain spotted fever.

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    9/35

    y Miscellaneous: liver disease, snakes bites,shock,heatstroke,vasculitis,aortic aneurysm, serotonin syndrome.

    yViral: Arena viruses causing Argentine hemorrhagic fever orBolivian hemorrhagic fever.

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    10/35

    PATHOPHYSIOLOGY

    DIC may caused by:

    1. Release or entry of tissue factors that act as coagulant

    into the blood stream.2. Extensive endothelial damage.

    Released coagulants are normally inactivated bynaturally occurring circulating inhibitors and are clearedby RE system.

    The occurrence of intravascular coagulation isaugmented by the stasis which prevents the circulatinginhibitors by reaching the coagulants and by REblockade.

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    11/35

    Pathophysiology ofDICy Activation of Blood Coagulation

    y Suppression of PhysiologicAnticoagulant Pathways

    y Impaired Fibrinolysisy Cytokines

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    12/35

    Pathophysiology ofDICy Activation of Blood Coagulation

    y Tissue factor/factor VIIa mediated thrombin generation via

    the extrinsic pathwayy complex activates factor IXand X

    y TF

    y endothelial cells

    y monocytes

    y Extravascular:

    y lung

    y kidney

    y epithelial cells

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    13/35

    Pathophysiology ofDICy Suppression of PhysiologicAnticoagulant Pathways

    y reduced antithrombin III levels

    y reduced activity of the protein C-protein S systemy Insufficient regulation of tissue factor activity by tissue factor

    pathway inhibitor (TFPI)

    y inhibits TF/FVIIa/Fxa complex activity

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    14/35

    Pathophysiology ofDICy Impaired Fibrinolysis

    y relatively suppressed at time of maximal activation of

    coagulation due to increased plasminogen activatorinhibitor type 1

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    15/35

    Coagulationy Intrinsic Pathwayy Extrinsic Pathwayy Common Pathwayy Contact Pathwayy

    Tissue Factor Pathwayy Primary factor in DIC

    5

    Contact Tissue Factor + VIITissue Factor + VII

    XIIIXIIIaa

    XIIIXIII

    ThrombinThrombin

    FibrinFibrin(strong)(strong)

    FibrinogenFibrinogen FibrinFibrin(weak)(weak)

    IXIX

    XIXI

    XIXIaa

    IXIXaa

    XXaaVVaa

    XIIXIIaa

    ProthrombinProthrombin

    TF-VIITF-VIIaa

    (Prothrombinase)(Prothrombinase)

    PLPL

    PLPL

    (Tenase)(Tenase)

    VIIIVIIIaa

    PLPL

    XX

    Intrinsic Pathway

    HKHKaa

    Extrinsic Pathway

    Common Pathway

    TF Pathway

    Coagulation PathwaysCoagulation Pathways

    Protein C, ProteinS, Antithrombin III

    Www.coumadin.com

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    16/35

    Anticlotting Mechanismsy Antithrombin III (ATIII):

    y The major inhibitor of thecoagulation cascade.

    y Inhibits Thrombiny Inhibits activated Factors IX, X,

    XI, and XII.

    y Activity is enhanced by heparin.

    y Tissue factor pathway inhibitorTFPI

    5

    Contact Tissue Factor + VIITissue Factor + VII

    XIIIXIIIaa

    XIIIXIII

    ThrombinThrombin

    FibrinFibrin(strong)(strong)

    FibrinogenFibrinogen FibrinFibrin(weak)(weak)

    IXIX

    XIXI

    XIXIaa

    IXIXaa

    XXaaVVaa

    XIIXIIaa

    ProthrombinProthrombin

    TF-VIITF-VIIaa

    (Prothrombinase)(Prothrombinase)

    PLPL

    PLPL

    (Tenase)(Tenase)

    VIIIVIIIaa

    PLPL

    XX

    Intrinsic Pathway

    HKHKaa

    Extrinsic Pathway

    Common Pathway

    TF Pathway

    Coagulation PathwaysCoagulation Pathways

    Protein C, Protein

    S, Antithrombin III

    Www.coumadin.com

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    17/35

    Anticlotting Mechanismsy Protein C

    y Activated byThrombin/Thrombomodulin

    y Anticoagulant and fibrinolyticactivity.

    y Vitamin K and Protein S arecofactors

    y Protein S

    5

    Contact Tissue Factor + VIITissue Factor + VII

    XIIIXIIIaa

    XIIIXIII

    ThrombinThrombin

    FibrinFibrin(strong)(strong)

    FibrinogenFibrinogen FibrinFibrin(weak)(weak)

    IXIX

    XIXI

    XIXIaa

    IXIXaa

    XXaaVVaa

    XIIXIIaa

    ProthrombinProthrombin

    TF-VIITF-VIIaa

    (Prothrombinase)(Prothrombinase)

    PLPL

    PLPL

    (Tenase)(Tenase)

    VIIIVIIIaa

    PLPL

    XX

    Intrinsic Pathway

    HKHKaa

    Extrinsic Pathway

    Common Pathway

    TF Pathway

    Coagulation PathwaysCoagulation Pathways

    Protein C, ProteinS, Antithrombin III

    Www.coumadin.com

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    18/35

    Fibrinolytic Systemy Plasmin

    y Produced fromPlasminogen by Tissue

    Plasminogen activator(TPA)

    y Degrades Fibrin andFibrinogen (Fibrindegradation products,

    FDP)y Degrades Factors V, VIII,IX, XI, and XII.

    y Activity is inhibited byAntiplasmin.

    7

    FibrinolysisFibrinolysisPlasminogen

    Plasmin

    Fibrin, fibrinogenFibrin, fibrinogen

    ActivationActivation

    Extrinsic: t-PA,Extrinsic: t-PA, urokinaseurokinase

    Intrinsic: factor XIIa, HMWK,Intrinsic: factor XIIa, HMWK, kallikreinkallikrein

    Exogenous:Exogenous: streptokinasestreptokinase

    Fibrin, fibrinogenFibrin, fibrinogen

    degradation productsdegradation products

    Www.coumadin.com

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    19/35

    Fibrinolytic Inhibitorsy Antiplasmin

    y Inactivates plasmin rapidly.

    y Acts slowly on plasminsequestered in the fibrin

    clot.

    y Inactivates factors XI and XIIslowly.

    y Plasminogen -ActivatorI

    nhibitor-1(PAI

    -1)y Inhibits the function of TPAy Also has some inhibitory

    activity against urokinase,plasmin, thrombin, activatedProtein C, factors and XII, and

    kallikrein

    7

    FibrinolysisF

    ibrinolysisPlasminogen

    Plasmin

    Fibrin, fibrinogenFibrin, fibrinogen

    ActivationActivation

    Extrinsic: t-PA,Extrinsic: t-PA, urokinaseurokinase

    Intrinsic: factor XIIa, HMWK,Intrinsic: factor XIIa, HMWK, kallikreinkallikrein

    Exogenous:Exogenous: streptokinasestreptokinase

    Fibrin, fibrinogenFibrin, fibrinogendegradation productsdegradation products

    Www.coumadin.com

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    20/35

    CLINICALFEATURES

    Two main clinical features of DIC

    1.Bleeding

    2.Organ damage

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    21/35

    Clinical Manifestations ofDICORGAN ISCHEMIC HEMOR.

    Skin Pur. FulminansGangrene

    Acral cyanosis

    Petechiae

    Echymosis

    OozingCNS Delirium/Coma

    Infarcts

    Intracranial

    bleeding

    Renal Oliguria/AzotemiaCortical Necrosis

    Hematuria

    Cardiovascular MyocardialDysfxn

    Pulmonary Dyspnea/HypoxiaInfarct

    Hemorrhagiclung

    GI

    Endocrine

    Ulcers, Infarcts

    Adrenal infarcts

    Massive

    hemorrhage.

    Ischemic Findingsareearliest!

    Bleedingisthemos obviousclinicalfinding

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    22/35

    Clinical Manifestations ofDIC

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    23/35

    Conditions Associated With DICy Malignancy

    y Leukemia

    y Metastatic diseasey Cardiovascular

    y Post cardiac arrest

    y Acute MI

    y Prosthetic devicesy Hypothermia/Hyperthermi

    a

    y Pulmonary

    y ARDS/RDS

    y Pulmonary embolismy Severe acidosis

    y Severe anoxia

    y Collagen vascular disease

    y Anaphylaxis

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    24/35

    Conditions Associated With DICy Infectious/Septicemia

    y Bacterialy

    Gm - / Gm +y Viral

    y CMV

    y Varicella

    y Hepatitis

    y Fungal

    y Intravascular hemolysis

    y Acute Liver Disease

    y Tissue Injuryy trauma

    y

    extensive surgeryy tissue necrosis

    y head trauma

    y Obstetricy Amniotic fluid emboli

    y Placental abruption

    y Eclampsia

    y Missed abortion

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    25/35

    Microscopic findings in DIC

    y Fragments

    y Schistocytesy Paucity of platelets

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    26/35

    Laboratory diagnosisy Thrombocytopeniay plat count

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    27/35

    Differential Diagnosisy Severe liver failure

    yVitamin K deficiency

    y Liver diseasey Thrombotic thrombocytopenic purpura

    y Congenital abnormalities of fibrinogen

    y HELLP syndrome

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    28/35

    Laboratory Tests Used in DICy D-dimer*

    y Antithrombin III*

    y F. 1+2*y FibrinopeptideA*

    y Platelet factor 4*

    y Fibrin Degradation Prod

    y Platelet count

    y Protamine test

    y Thrombin time

    y Fibrinogen

    y Prothrombin timey Activated PTT

    y Protamine test

    y Reptilase time

    y Coagulation factor levels

    *Most reliable test

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    29/35

    Treatment ofDICy Stopthetriggeringprocess .

    y The only proven treatment!

    y Supportive therapyy No specific treatments

    y Plasma and platelet substitution therapy

    y Anticoagulants

    y Physiologic coagulation inhibitors

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    30/35

    Plasma therapyy Indications

    y Active bleeding

    y Patient requiring invasive procedures

    y Patient at high risk for bleeding complications

    y Prophylactic therapy has no proven benefit.

    y Cons:

    y Fresh frozen plasma(FFP):y provides clotting factors, fibrinogen, inhibitors, and platelets in

    balanced amounts.y Usual dose is 10-15 ml/kg

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    31/35

    Platelet therapyy Indications

    y Active bleeding

    y Patient requiring invasive proceduresy Patient at high risk for bleeding complications

    y Platelets

    y approximate dose 1 unit/10kg

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    32/35

    Bloody Replaced as needed to maintain adequate oxygen delivery.

    y Blood loss due to bleeding

    y

    RBC destruction (hemolysis)

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    33/35

    Summaryy DIC is a syndrome characterized systemic intravascular

    coagulation.

    y

    Coagulation is the initial event and the extent of intravascularthrombosis has the greatest impact on morbidity and mortality.

    y Important link between inflammation and coagulation.

    y Morbidity and mortality remain high.

    y The only proven treatment is reversal or control of the

    underlying cause.

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    34/35

    REFERENCES

    y De Gruchys Clinical haematology in medical practice 5th

    edu.

    y

    www.coumdin.com.y Teachers note.

  • 8/3/2019 Disseminated Intravascular Dic Auto Saved]

    35/35

    y

    THA

    NK YOU